Adjunctive lamotrigine therapy in patients with refractory seizures: a lifetime cost-utility analysis. [electronic resource]
- European journal of clinical pharmacology Feb 1998
- 421-7 p. digital
Publication Type: Journal Article
0031-6970
10.1007/s002280050402 doi
Adjuvants, Pharmaceutic--economics Adult Anticonvulsants--economics Cost of Illness Cost-Benefit Analysis Epilepsy--drug therapy Female Humans Lamotrigine Male Prospective Studies Quality-Adjusted Life Years Retrospective Studies Triazines--economics